+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
544370 NUKLEUS

Nukleus Office Solutions Share Price

 

 

Nukleus Office Solutions live price: ₹228.5. It opened at ₹224 vs previous close ₹224; intraday high/low: ₹229/₹224. The 50 DMA stands at ₹206.52.

Nukleus Office Solutions Performance

  • Today's Low
  • ₹224
  • Today's High
  • ₹229
  • 52 Week Low
  • ₹143
  • 52 Week High
  • ₹240
  • Open Price₹224
  • Previous Close₹224
  • Volume3,000
  • 50 DMA₹206.52
  • 100 DMA₹199.76
  • 200 DMA-

Nukleus Office Solutions Chart

Investment Returns

  • Over 1 Month + 9.86%
  • Over 3 Month + 21.54%
  • Over 6 Month + 15.4%
  • Over 1 Year + 29.46%

Smart Investing Starts Here Start SIP with Nukleus Office Solutions for Steady Growth!

Invest Now

Nukleus Office Solutions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 43.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 92
  • P/B Ratio
  • 2.2
  • Average True Range
  • 5.98
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.11
  • RSI
  • 74.42
  • MFI
  • 79.23

Nukleus Office Solutions Financials

Nukleus Office Solutions Technicals

EMA & SMA

Current Price
₹228.50
+ 4.5 (2.01%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 14
  • 20 Day
  • ₹213.00
  • 50 Day
  • ₹206.50
  • 100 Day
  • ₹199.80
  • 200 Day
  • -

Resistance and Support

227 Pivot Speed
  • R3 234.50
  • R2 231.50
  • R1 230.00
  • S1 225.50
  • S2 222.50
  • S3 221.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nukleus provides flexible workspace solutions, including coworking spaces, private offices, and managed offices, catering to startups, SMEs, and enterprises. With multiple locations across the NCR region, Nukleus fosters productivity, collaboration, and innovation, offering modern office solutions designed for efficiency and business growth.

Nukleus Office Solutions Ltd has an operating revenue of Rs. 56.86 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 8% is okay, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 38%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 21% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 86 indicates it belongs to a poor industry group of Bldg-Heavy Construction and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nukleus Office Solutions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-16 Audited Results
2025-11-11 Half Yearly Results
2025-05-22 Audited Results

Nukleus Office Solutions Shareholding Pattern

69.91%
19.9%
10.19%

Nukleus Office Solutions FAQs

Nukleus Office Solutions share price is ₹228 As on 22 June, 2026 | 05:12

The Market Cap of Nukleus Office Solutions is ₹92.1 Cr As on 22 June, 2026 | 05:12

The P/E ratio of Nukleus Office Solutions is 43.1 As on 22 June, 2026 | 05:12

The PB ratio of Nukleus Office Solutions is 2.2 As on 22 June, 2026 | 05:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23